Complain about a product or service

Chiron Cleared To Ship Flu Vaccine

October 14, 2005

• More Flu Shots for Kids • Record Amount Of Flu Vaccine On Hand • Nasty Flu Year in Store • Nasal Flu Vaccine Approved For Young Children • FDA OKs Relenza for Treatment and Prevention of Flu • Expanded Flu Shot Recommendations for Children • CDC Revises Flu Treatment Guidelines • Flu Outbreak Jams California Emergency Rooms • FDA Approves Tamiflu for Prevention of Flu in Children • Do Flu Shots Really Help Seniors? • No Surprises in Use of Nasal Spray Flu Vaccine • Flu Expert Wants Mandatory Vaccination of Health Care Workers • Like the Flu, Vaccine Shortages Return • Chiron Cleared To Ship Flu Vaccine • Flu Shots' Benefit to Elderly Questioned --- • U.S. Fears Devastating "Bird Flu" Pandemic

While world health officials focus on concerns of a possible "bird flu" pandemic, health care providers are gearing up for another season of dealing with ordinary flu bugs. Within days, they should begin receiving shipments of the first vaccine since last year’s contamination problems cut the U.S vaccine supply in half.

Flu Vaccine • FDA: Plenty Of Flu Vaccine • Chiron Cleared To Ship Flu Vaccine • Flu Shots' Benefit to Elderly Questioned 2005-2005 Flu Season • Chiron To Resume Flu Vaccine Production • Meds-Stat Turns Over Vaccine to Florida • Enough Vaccine, Medicine, Thompson Says • Feds Join Florida in Flu Suit • Texas Sues Vaccine Distributors • Kansas Alleges Price Gouging • HHS Sets Flu Priorities • Flu Vaccine Shortage -- • U.S. Fears Devastating "Bird Flu" Pandemic • Who Needs a Flu Shot?

This year, Chiron Corp. says there were no production problems and U.S. health agencies have cleared about 1.5 million doses of the vaccine for distribution. The company says the shipments will take place in a few days, following some final tests.

“The process will continue through this month and into November and December," a spokeswoman said.

Last year, U.S. health care providers were thrown into a panic after Chiron lost the manufacturing license for its British flu vaccine plant, meaning it could send none of its vaccine to the U.S. The U.S. had planned to obtain half its supply from Chiron.

Chiron worked for months to correct the bacterial contamination problems that resulted in the suspension of sales, and the British plant was cleared by U.S. inspectors at the end of the summer.

Confusion reigned during last year’s flu season. In some areas there were shortages, resulting in long lines and pleas to the low-risk population to forego flu shots in favor of more vulnerable groups. By the end of the season, however, there was vaccine left over that was never used.

Health authorities say there should be no such problem this year. The total U.S. supply for the upcoming flu season is expected to range from 71 million to 97 million doses.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.